As the world is set to ring in 2017 in just a few short days, investors are in the process of adjusting their stock picks for the next year, which could potentially see a corporate tax reform, higher interest rates, the repeal of the Affordable Care Act and reduced regulation under the Trump administration.
Apart from the macro factors, company-specific factors are also anticipated to bring a swing of fortunes that may hit the top line.
In this backdrop, Benzinga brings you the list of six stocks with the lowest forecast sales growth. The criteria: trailing 12-month revenue of greater than $20 million. The following list will showcase small- and mid-cap companies expected to generate weaker 2017 sales versus last year, as projected by Wall Street consensus.
Symbol |
Name |
Revenue (TTM) |
Revenue Est. For Current Fiscal Year |
Revenue Est. For Next Fiscal Year |
ATW |
Atwood Oceanics, Inc. ATW |
1.021 billion
|
1.026 billion
|
525.21 million |
CYTK |
Cytokinetics, Inc. CYTK |
83.03 million |
85.04 million |
40.13 million |
NADL |
North Atlantic Drilling Ltd. NADL |
603.30 million |
529.45 million |
236.38 million |
OPHT |
Ophthotech Corp OPHT |
50.37 million |
51.20 million |
8.00 million |
PFNX |
Pfenex Inc PFNX |
57.98 million |
57.20 million |
10.00 million |
UUUU |
Energy Fuels Inc (USA) UUUU |
44.59 million
|
54.45 million |
25.66 million |
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.